Fig. 6. Different levels of CXCL10 between groups in month 3, month 6, month 9, and month 12. ANOVA test was applied. The levels of CXCL10 in patients who had NSV with both alopecia areata (AA) and autoimmune thyroid disease (AITD) were higher than in those who had non-segmental vitiligo (NSV) with AA or AITD alone in month 3 (A) and 6 (B). The levels of CXCL10 in patients who had NSV with either AA or AITD were higher than in those who had NSV without AA or AITD in month 3 (A), 6 (B), 9 (C), and 12 (D). NS: no significance. ^*p<0.05, ^**p<0.01, ^***p<0.001, ^****p<0.0001.